Søren Gregersen 300x200.png

Fredrik Brustad Mellbye, M.D.

PhD student, enrolled 2019
Department - text will follow


fbmellbye@clin.au.dk


Main supervisor: Søren Gregersen

Research Area

  • Text will follow

Research description

  • Effects of cafestol, a potential antidiabetic substance in coffee, in subjects at risk of type 2 diabetes
    Coffee consumption is inversely associated with risk of Type-2-diabetes (T2D). I have previously discovered that cafestol, a bioactive substance in coffee, increases insulin secretion from rat beta cells, increases glucose uptake in skeletal muscle cells and postpones development of T2D in a KKAy-mice I an animal intervention study. Now, in my PhD, I investigate potential antidiabetic effects of cafestol in humans at high risk of deceloping T2D.

Find me on

  • Text will follow